Treace Medical Concepts (TMCI) Shares Outstanding (Diluted Average) (2020 - 2026)

Treace Medical Concepts has reported Shares Outstanding (Diluted Average) for 7 years, with the latest figure at $64.6 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 3.08% year-over-year to $64.6 million; the trailing twelve-month figure through Mar 2026 stood at $64.6 million (up 3.08% YoY), and the FY2025 full-year result was $63.3 million, up 1.86% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $64.6 million, up from $63.3 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $64.6 million in Q1 2026, with the low at $54.8 million in Q1 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $60.4 million across 5 years, with a median of $61.8 million in 2024.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) grew 18.43% — and 2024, when it grew 1.08%.
• Treace Medical Concepts' Shares Outstanding (Diluted Average) stood at $55.3 million in 2022, then increased by 10.09% to $60.9 million in 2023, then gained by 2.07% to $62.1 million in 2024, then advanced by 1.86% to $63.3 million in 2025, then gained by 2.09% to $64.6 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $64.6 million (Q1 2026), $63.3 million (Q4 2025), and $63.1 million (Q3 2025), per Business Quant data.